{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:38:18Z","timestamp":1793363898535,"version":"4.5.0"},"reference-count":142,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p>MicroRNAs (miRNAs) are short (18\u201325\u00a0nt), non-coding, widely conserved RNA molecules responsible for regulating gene expression via sequence-specific post-transcriptional mechanisms. Since the human miRNA transcriptome regulates the expression of a number of tumor suppressors and oncogenes, its dysregulation is associated with the clinical onset of different types of cancer. Despite the fact that numerous therapeutic approaches have been designed in recent years to treat cancer, the complexity of the disease manifested by each patient has prevented the development of a highly effective disease management strategy. However, over the past decade, artificial miRNAs (i.e., anti-miRNAs and miRNA mimics) have shown promising results against various cancer types; nevertheless, their targeted delivery could be challenging. Notably, numerous reports have shown that nanotechnology-based delivery of miRNAs can greatly contribute to hindering cancer initiation and development processes, representing an innovative disease-modifying strategy against cancer. Hence, in this review, we evaluate recently developed nanotechnology-based miRNA drug delivery systems for cancer therapeutics and discuss the potential challenges and future directions, such as the promising use of plant-made nanoparticles, phytochemical-mediated modulation of miRNAs, and nanozymes.<\/jats:p>","DOI":"10.3389\/fbioe.2023.1208547","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T10:26:30Z","timestamp":1690453590000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":57,"title":["Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives"],"prefix":"10.3389","volume":"11","author":[{"given":"Luis Alberto","family":"Bravo-V\u00e1zquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"M\u00e9ndez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma L.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmavati","family":"Sahare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surajit","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antara","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim K.","family":"Duttaroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujay","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1039\/D0BM00015A","article-title":"Delivery of dual miRNA through CD44-targeted mesoporous silica nanoparticles for enhanced and effective triple-negative breast cancer therapy","volume":"8","author":"Ahir","year":"2020","journal-title":"Biomater. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3390\/ijms21051723","article-title":"Regulatory mechanism of MicroRNA expression in cancer","volume":"21","author":"Ali Syeda","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"104885","DOI":"10.1016\/j.yrtph.2021.104885","article-title":"Regulatory landscape of nanotechnology and nanoplastics from a global perspective","volume":"122","author":"Allan","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/21691401.2022.2092123","article-title":"MicroRNA-219 loaded chitosan nanoparticles for treatment of glioblastoma","volume":"50","author":"Alswailem","year":"2022","journal-title":"Artif. Cells, Nanomedicine Biotechnol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.drudis.2019.11.006","article-title":"Improving the therapeutic efficiency of noncoding RNAs in cancers using targeted drug delivery systems","volume":"25","author":"Alzhrani","year":"2020","journal-title":"Drug Discov. Today"},{"key":"B7","doi-asserted-by":"publisher","first-page":"103386","DOI":"10.1016\/j.drudis.2022.103386","article-title":"Inorganic nanoparticle-based advanced cancer therapies: Promising combination strategies","volume":"27","author":"Amaldoss","year":"2022","journal-title":"Drug Discov. Today"},{"key":"B8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.semcancer.2019.12.022","article-title":"Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: Prospects for the therapeutic management of breast cancer","volume":"69","author":"Ansari","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"102638","DOI":"10.1016\/j.jddst.2021.102638","article-title":"Biodegradable nanoparticles as drug delivery devices","volume":"64","author":"Anwar","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"100877","DOI":"10.1016\/j.aohep.2022.100877","article-title":"Daytime napping and risk of liver cancer: A large population-based prospective cohort study","volume":"28","author":"Arafa","year":"2023","journal-title":"Ann. Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: Global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast"},{"key":"B12","doi-asserted-by":"publisher","first-page":"100031","DOI":"10.1016\/j.bea.2022.100031","article-title":"Development of magnetic nanoparticles for the intracellular delivery of miR-148b in non-small cell lung cancer","volume":"3","author":"Arrizabalaga","year":"2022","journal-title":"Biomed. Eng. Adv."},{"key":"B13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/17425247.2022.2063835","article-title":"Current progress of miRNA-derivative nucleotide drugs: Modifications, delivery systems, applications","volume":"19","author":"Asakiya","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"B14","doi-asserted-by":"publisher","first-page":"106706","DOI":"10.1016\/j.phrs.2023.106706","article-title":"Artificial intelligence in liver cancers: Decoding the impact of machine learning models in clinical diagnosis of primary liver cancers and liver cancer metastases","volume":"189","author":"Bakrania","year":"2023","journal-title":"Pharmacol. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1111\/febs.16160","article-title":"Capturing the RNA castle: Exploiting MicroRNA inhibition for wound healing","volume":"289","author":"Bibby","year":"2022","journal-title":"FEBS J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"102916","DOI":"10.1016\/j.jddst.2021.102916","article-title":"Stimuli-responsive nanoliposomes as prospective nanocarriers for targeted drug delivery","volume":"66","author":"Bilal","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1016\/j.cllc.2022.05.007","article-title":"Clinical-molecular prospective cohort study in non-small cell lung cancer (promole study): A comprehensive approach to identify new predictive markers of pharmacological response","volume":"23","author":"Bironzo","year":"2022","journal-title":"Clin. Lung Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00018-019-03317-9","article-title":"Nanoscale delivery systems for microRNAs in cancer therapy","volume":"77","author":"Boca","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"101579","DOI":"10.1016\/j.tranon.2022.101579","article-title":"MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications","volume":"27","author":"Bravo-V\u00e1zquez","year":"","journal-title":"Transl. Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s10620-022-07516-6","article-title":"Functional implications and clinical potential of MicroRNAs in irritable bowel syndrome: A concise review","volume":"68","author":"Bravo-V\u00e1zquez","year":"","journal-title":"Dig. Dis. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3390\/molecules27010211","article-title":"The emerging role of MicroRNAs in bone diseases and their therapeutic potential","volume":"27","author":"Bravo-V\u00e1zquez","year":"2022","journal-title":"Molecules"},{"key":"B22","doi-asserted-by":"publisher","first-page":"11827","DOI":"10.1093\/nar\/gkaa670","article-title":"Investigating the pharmacodynamic durability of GalNAc-siRNA conjugates","volume":"48","author":"Brown","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.radonc.2021.03.012","article-title":"Deciphering the epigenetic network in cancer radioresistance","volume":"159","author":"Cabrera-Licona","year":"2021","journal-title":"Radiother. Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1038\/s41598-022-08185-1","article-title":"MiR-206 conjugated gold nanoparticle based targeted therapy in breast cancer cells","volume":"12","author":"Chaudhari","year":"2022","journal-title":"Sci. Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.addr.2014.05.009","article-title":"In vivo delivery of miRNAs for cancer therapy: Challenges and strategies","volume":"81","author":"Chen","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"111722","DOI":"10.1016\/j.msec.2020.111722","article-title":"Vitamin-B12-conjugated PLGA-PEG nanoparticles incorporating miR-532-3p induce mitochondrial damage by targeting apoptosis repressor with caspase recruitment domain (ARC) on CD320-overexpressed gastric cancer","volume":"120","author":"Chen","year":"2021","journal-title":"Mat. Sci. Eng. C"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e10374","DOI":"10.1002\/btm2.10374","article-title":"RNA therapeutics in the clinic","volume":"8","author":"Curreri","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"628137","DOI":"10.3389\/fbioe.2021.628137","article-title":"The limitless future of RNA therapeutics","volume":"9","author":"Damase","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/mps4010010","article-title":"Recent advances in miRNA delivery systems","volume":"4","author":"Dasgupta","year":"2021","journal-title":"Methods Protoc."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.3390\/cancers14122954","article-title":"A tale of two cancers: A current concise overview of breast and prostate cancer","volume":"14","author":"De Silva","year":"2022","journal-title":"Cancers"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.ymthe.2020.06.015","article-title":"Delivery of oligonucleotides to the liver with GalNAc: From research to registered therapeutic drug","volume":"28","author":"Debacker","year":"2020","journal-title":"Mol. Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.3390\/ijms21093084","article-title":"MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance","volume":"21","author":"Desantis","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3390\/cells8121492","article-title":"MicroRNAs involved in carcinogenesis, prognosis, therapeutic resistance, and applications in human triple-negative breast cancer","volume":"8","author":"Ding","year":"2019","journal-title":"Cells"},{"key":"B35","doi-asserted-by":"publisher","first-page":"121256","DOI":"10.1016\/j.ijpharm.2021.121256","article-title":"Targeted delivery of miR-218 via decorated hyperbranched polyamidoamine for liver cancer regression","volume":"610","author":"Elfiky","year":"2021","journal-title":"Int. J. Pharm."},{"key":"B36","doi-asserted-by":"publisher","first-page":"102667","DOI":"10.1016\/j.nano.2023.102667","article-title":"Ligand-displaying-exosomes using RNA nanotechnology for targeted delivery of multi-specific drugs for liver cancer regression","volume":"50","author":"Ellipilli","year":"2023","journal-title":"Nanomedicine Nanotechnol. Biol. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1186\/s12889-022-13224-7","article-title":"Women\u2019s awareness of breast cancer symptoms: A national cross-sectional study from Palestine","volume":"22","author":"Elshami","year":"2022","journal-title":"BMC Public Health"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3390\/cancers12071852","article-title":"A comprehensive review of cancer MicroRNA therapeutic delivery strategies","volume":"12","author":"Forterre","year":"2020","journal-title":"Cancers"},{"key":"B39","doi-asserted-by":"publisher","first-page":"736323","DOI":"10.3389\/fphar.2021.736323","article-title":"MicroRNA as an important target for anticancer drug development","volume":"12","author":"Fu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"117608","DOI":"10.1016\/j.lfs.2020.117608","article-title":"Tumor development in rats and cancer cachexia are reduced by treatment with botryosphaeran by increasing apoptosis and improving the metabolic profile","volume":"252","author":"Geraldelli","year":"2020","journal-title":"Life Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s10529-021-03085-2","article-title":"Co-delivery of miRNA-15a and miRNA-16\u20131 using cationic PEGylated niosomes downregulates Bcl-2 and induces apoptosis in prostate cancer cells","volume":"43","author":"Ghaffari","year":"2021","journal-title":"Biotechnol. Lett."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.3390\/ijms21093363","article-title":"Mitochondria targeting as an effective strategy for cancer therapy","volume":"21","author":"Ghosh","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"689245","DOI":"10.3389\/fbioe.2021.689245","article-title":"Nanoparticle-based therapies for turning cold tumors hot: How to treat an immunosuppressive tumor microenvironment","volume":"9","author":"Giustarini","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/08839115221095152","article-title":"Delivery of miRNA-126 through folic acid-targeted biocompatible polymeric nanoparticles for effective lung cancer therapy","volume":"37","author":"Golafzani","year":"2022","journal-title":"J. Bioact. Compat. Polym."},{"key":"B45","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.omtn.2021.01.016","article-title":"ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer","volume":"23","author":"Gorur","year":"2021","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"B46","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/jfb13040207","article-title":"Bio-inspired smart nanoparticles in enhanced cancer theranostics and targeted drug delivery","volume":"13","author":"Gulia","year":"2022","journal-title":"J. Funct. Biomater."},{"key":"B47","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/pharmaceutics14010106","article-title":"Development of pharmaceutical nanomedicines: From the bench to the market","volume":"14","author":"Halwani","year":"2022","journal-title":"Pharmaceutics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"101756","DOI":"10.1016\/j.inat.2023.101756","article-title":"The clinical progression of patients with glioblastoma","volume":"32","author":"Hansen","year":"2023","journal-title":"Interdiscip. Neurosurg."},{"key":"B49","doi-asserted-by":"publisher","first-page":"100317","DOI":"10.1016\/j.mtadv.2022.100317","article-title":"Multifunctional miR181a nanoparticles promote highly efficient radiotherapy for rectal cancer","volume":"16","author":"Hao","year":"2022","journal-title":"Mat. Today Adv."},{"key":"B50","doi-asserted-by":"publisher","first-page":"591","DOI":"10.4155\/tde-2020-0052","article-title":"Progress in systemic co-delivery of microRNAs and chemotherapeutics for cancer treatment by using lipid-based nanoparticles","volume":"11","author":"He","year":"2020","journal-title":"Ther. Deliv."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","article-title":"Global burden and trends in premenopausal and postmenopausal breast cancer: A population-based study","volume":"8","author":"Heer","year":"2020","journal-title":"Lancet Glob. heal."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.3390\/cells11152332","article-title":"MicroRNAs and their big therapeutic impacts: Delivery strategies for cancer intervention","volume":"11","author":"Holjencin","year":"2022","journal-title":"Cells"},{"key":"B53","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.brainresbull.2023.03.006","article-title":"Hypocretin-1 suppresses malignant progression of glioblastoma cells through Notch1 signaling pathway","volume":"196","author":"Huan","year":"2023","journal-title":"Brain Res. Bull."},{"key":"B54","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s10038-021-00938-6","article-title":"Cancer-associated miRNAs and their therapeutic potential","volume":"66","author":"Inoue","year":"2021","journal-title":"J. Hum. Genet."},{"key":"B55","doi-asserted-by":"publisher","first-page":"8055","DOI":"10.1021\/acssuschemeng.9b00954","article-title":"Plant-derived edible nanoparticles and miRNAs: Emerging frontier for therapeutics and targeted drug-delivery","volume":"7","author":"Iravani","year":"2019","journal-title":"ACS Sustain. Chem. Eng."},{"key":"B56","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jconrel.2020.07.003","article-title":"A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer","volume":"326","author":"Jain","year":"2020","journal-title":"J. Control. Release"},{"key":"B57","doi-asserted-by":"publisher","first-page":"624494","DOI":"10.3389\/fmolb.2020.624494","article-title":"Nanotechnology-based strategies for berberine delivery system in cancer treatment: Pulling strings to keep berberine in power","volume":"7","author":"Javed Iqbal","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"112200","DOI":"10.1016\/j.jinorgbio.2023.112200","article-title":"Synthesis and biological evaluation of cholic acid-conjugated oxaliplatin as a new prodrug for liver cancer","volume":"243","author":"Jiang","year":"2023","journal-title":"J. Inorg. Biochem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jconrel.2021.01.018","article-title":"Co-delivery of curcumin and miRNA-144-3p using heart-targeted extracellular vesicles enhances the therapeutic efficacy for myocardial infarction","volume":"331","author":"Kang","year":"","journal-title":"J. Control. Release"},{"key":"B60","doi-asserted-by":"publisher","first-page":"120907","DOI":"10.1016\/j.biomaterials.2021.120907","article-title":"Efficient and precise delivery of microRNA by photoacoustic force generated from semiconducting polymer-based nanocarriers","volume":"275","author":"Kang","year":"","journal-title":"Biomaterials"},{"key":"B61","doi-asserted-by":"publisher","first-page":"114113","DOI":"10.1016\/j.addr.2022.114113","article-title":"RNAi-based therapeutics and tumor targeted delivery in cancer","volume":"182","author":"Kara","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B62","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12011-019-01895-0","article-title":"Efficiency of the green synthesized nanoparticles as new tools in cancer therapy: Insights on plant-based bioengineered nanoparticles, biophysical properties, and anticancer roles","volume":"196","author":"Karmous","year":"2020","journal-title":"Biol. Trace Elem. Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2035659","DOI":"10.1080\/19490976.2022.2035659","article-title":"Next-generation probiotics \u2013 do they open new therapeutic strategies for cancer patients?","volume":"14","author":"Ka\u017amierczak-Siedlecka","year":"2022","journal-title":"Gut Microbes"},{"key":"B64","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12272-019-01115-2","article-title":"Targeting cancer energy metabolism: A potential systemic cure for cancer","volume":"42","author":"Kim","year":"2019","journal-title":"Arch. Pharm. Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bbrc.2020.04.076","article-title":"Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer","volume":"527","author":"Kobayashi","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B66","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"key":"B67","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/cancers11040456","article-title":"TRAILblazing strategies for cancer treatment","volume":"11","author":"Kretz","year":"2019","journal-title":"Cancers"},{"key":"B68","doi-asserted-by":"publisher","first-page":"100904","DOI":"10.1016\/j.drup.2022.100904","article-title":"Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment","volume":"66","author":"Li","year":"2023","journal-title":"Drug resist. updat."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e1838","DOI":"10.1002\/wnan.1838","article-title":"Nanotechnology meets glioblastoma multiforme: Emerging therapeutic strategies","volume":"15","author":"Liu","year":"2023","journal-title":"Wiley Interdiscip. Rev. Nanomedicine Nanobiotechnology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"121036","DOI":"10.1016\/j.biomaterials.2021.121036","article-title":"Polymeric nanoparticle mediated inhibition of miR-21 with enhanced miR-124 expression for combinatorial glioblastoma therapy","volume":"276","author":"Liu","year":"2021","journal-title":"Biomaterials"},{"key":"B71","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.actbio.2022.09.027","article-title":"Tumor pH-functionalized and charge-tunable nanoparticles for the nucleus\/cytoplasm-directed delivery of oxaliplatin and miRNA in the treatment of head and neck cancer","volume":"153","author":"Lo","year":"2022","journal-title":"Acta Biomater."},{"key":"B72","doi-asserted-by":"publisher","first-page":"100200","DOI":"10.1016\/j.apjon.2023.100200","article-title":"The high burden of symptoms associated with cognitive impairment in lung cancer patients: A latent class analysis","volume":"10","author":"Luo","year":"2023","journal-title":"Asia-Pacific J. Oncol. Nurs."},{"key":"B73","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.actbio.2022.11.016","article-title":"A miRNA-based gene therapy nanodrug synergistically enhances pro-inflammatory antitumor immunity against melanoma","volume":"155","author":"Ma","year":"2023","journal-title":"Acta Biomater."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/7816200","article-title":"Systematic framework to predict early-stage liver carcinoma using hybrid of feature selection techniques and regression techniques","volume":"2022","author":"Mehmood","year":"2022","journal-title":"Complexity"},{"key":"B75","doi-asserted-by":"publisher","first-page":"103183","DOI":"10.1016\/j.critrevonc.2020.103183","article-title":"miRNA as promising theragnostic biomarkers for predicting radioresistance in cancer: A systematic review and meta-analysis","volume":"157","author":"Mohammadi","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"12369","DOI":"10.1002\/jcp.28058","article-title":"MicroRNA replacement therapy in cancer","volume":"234","author":"Mollaei","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.semcdb.2021.04.001","article-title":"The emerging role of miRNA in the perturbation of tumor immune microenvironment in chemoresistance: Therapeutic implications","volume":"124","author":"Mondal","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jconrel.2020.08.012","article-title":"Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies","volume":"327","author":"Moradi Kashkooli","year":"2020","journal-title":"J. Control. Release"},{"key":"B79","doi-asserted-by":"publisher","first-page":"112258","DOI":"10.1016\/j.msec.2021.112258","article-title":"Smart co-delivery of miR-34a and cytotoxic peptides (LTX-315 and melittin) by chitosan based polyelectrolyte nanocarriers for specific cancer cell death induction","volume":"128","author":"Motiei","year":"2021","journal-title":"Mat. Sci. Eng. C"},{"key":"B80","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/nano12030399","article-title":"Advanced optical imaging-guided nanotheranostics towards personalized cancer drug delivery","volume":"12","author":"Murar","year":"2022","journal-title":"Nanomaterials"},{"key":"B81","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jconrel.2020.09.034","article-title":"Manipulating immune system using nanoparticles for an effective cancer treatment: Combination of targeted therapy and checkpoint blockage miRNA","volume":"329","author":"Nguyen","year":"2021","journal-title":"J. Control. Release"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3390\/cells9071651","article-title":"CSC radioresistance: A therapeutic challenge to improve radiotherapy effectiveness in cancer","volume":"9","author":"Olivares-Urbano","year":"2020","journal-title":"Cells"},{"key":"B83","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3390\/cells9020521","article-title":"Nanoparticle-based delivery of tumor suppressor microRNA for cancer therapy","volume":"9","author":"O\u2019Neill","year":"2020","journal-title":"Cells"},{"key":"B84","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.biochi.2021.05.015","article-title":"Roles of microRNAs in carbohydrate and lipid metabolism disorders and their therapeutic potential","volume":"187","author":"Paul","year":"","journal-title":"Biochimie"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.3390\/cells9071698","article-title":"Current status of microRNA-based therapeutic approaches in neurodegenerative disorders","volume":"9","author":"Paul","year":"","journal-title":"Cells"},{"key":"B86","doi-asserted-by":"publisher","first-page":"198631","DOI":"10.1016\/j.virusres.2021.198631","article-title":"The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review","volume":"308","author":"Paul","year":"2022","journal-title":"Virus Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1007\/s13577-021-00540-0","article-title":"Current insight into the functions of microRNAs in common human hair loss disorders: A mini review","volume":"34","author":"Paul","year":"","journal-title":"Hum. Cell"},{"key":"B88","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s11064-019-02917-y","article-title":"MicroRNAs and child neuropsychiatric disorders: A brief review","volume":"45","author":"Paul","year":"","journal-title":"Neurochem. Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s13205-020-02498-6","article-title":"Human microRNAs in host\u2013parasite interaction: A review","volume":"10","author":"Paul","year":"","journal-title":"3 Biotech."},{"key":"B90","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s13770-022-00430-y","article-title":"Nanozyme-based enhanced cancer immunotherapy","volume":"19","author":"Phan","year":"2022","journal-title":"Tissue Eng. Regen. Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/ijc.33232","article-title":"Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050","volume":"148","author":"Pilleron","year":"2021","journal-title":"Int. J. Cancer"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3390\/cancers12061662","article-title":"Non-coding RNAs in cancer radiosensitivity: MicroRNAs and lncRNAs as regulators of radiation-induced signaling pathways","volume":"12","author":"Podralska","year":"2020","journal-title":"Cancers"},{"key":"B93","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00018-018-2940-7","article-title":"Regulatory network of miRNA on its target: Coordination between transcriptional and post-transcriptional regulation of gene expression","volume":"76","author":"Pu","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"105655","DOI":"10.1016\/j.phrs.2021.105655","article-title":"Plant-based vaccines and cancer therapy: Where are we now and where are we going?","volume":"169","author":"Rahimian","year":"2021","journal-title":"Pharmacol. Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/17425247.2022.2044785","article-title":"Opportunities in combinational chemo-immunotherapy for breast cancer using nanotechnology: An emerging landscape","volume":"19","author":"Raikwar","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"B96","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cllc.2023.01.005","article-title":"Association of reported candidate monogenic genes with lung cancer risk","volume":"24","author":"Rifkin","year":"2023","journal-title":"Clin. Lung Cancer"},{"key":"B97","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/biom12060784","article-title":"Nano-based approved pharmaceuticals for cancer treatment: Present and future challenges","volume":"12","author":"Rodr\u00edguez","year":"2022","journal-title":"Biomolecules"},{"key":"B98","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.tibtech.2022.12.019","article-title":"RNA and nanocarriers: Next generation drug and delivery platform take center stage","volume":"41","author":"Rouge","year":"2023","journal-title":"Trends Biotechnol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.semcdb.2021.04.006","article-title":"Therapeutic strategies for miRNA delivery to reduce hepatocellular carcinoma","volume":"124","author":"Roy","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e001021","DOI":"10.1136\/esmoopen-2020-001021","article-title":"Lung cancer symptoms at diagnosis: Results of a nationwide registry study","volume":"5","author":"Ruano-Ravi\u00f1a","year":"2020","journal-title":"ESMO Open"},{"key":"B101","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ptr.7338","article-title":"Phytochemicals mediated modulation of microRNAs and long non-coding RNAs in cancer prevention and therapy","volume":"36","author":"Ruiz-Manriquez","year":"2022","journal-title":"Phyther. Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"100084","DOI":"10.1016\/j.focus.2023.100084","article-title":"Lung cancer screening among U.S. Military veterans by health status and race and ethnicity, 2017\u20132020: A cross-sectional population-based study","volume":"2","author":"Rustagi","year":"2023","journal-title":"AJPM Focus"},{"key":"B103","doi-asserted-by":"publisher","first-page":"118387","DOI":"10.1016\/j.lfs.2020.118387","article-title":"Modulation of telomerase expression and function by miRNAs: Anti-cancer potential","volume":"259","author":"Salamati","year":"2020","journal-title":"Life Sci."},{"key":"B104","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3390\/jpm13020369","article-title":"The role of molecular imaging in personalized medicine","volume":"13","author":"Salih","year":"2023","journal-title":"J. Pers. Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"B106","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1080\/17460441.2020.1765770","article-title":"Challenges identifying efficacious miRNA therapeutics for cancer","volume":"15","author":"Segal","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"key":"B107","doi-asserted-by":"publisher","first-page":"112564","DOI":"10.1016\/j.biopha.2021.112564","article-title":"Dual antisense oligonucleotide targeting miR-21\/miR-155 synergize photodynamic therapy to treat triple-negative breast cancer and inhibit metastasis","volume":"146","author":"Shang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1166\/jbn.2020.2989","article-title":"Delivery of MicroRNA-let-7c-5p by biodegradable silica nanoparticles suppresses human cervical carcinoma cell proliferation and migration","volume":"16","author":"Shao","year":"2020","journal-title":"J. Biomed. Nanotechnol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"112305","DOI":"10.1016\/j.msec.2021.112305","article-title":"Folate targeted hybrid lipo-polymeric nanoplexes containing docetaxel and miRNA-34a for breast cancer treatment","volume":"128","author":"Sharma","year":"2021","journal-title":"Mat. Sci. Eng. C"},{"key":"B110","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3390\/vaccines9080830","article-title":"Frontiers in bioengineering and Biotechnology: Plant nanoparticles for anti-cancer therapy","volume":"9","author":"Shoeb","year":"2021","journal-title":"Vaccines"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.3390\/ijms24031980","article-title":"The role of different types of microRNA in the pathogenesis of breast and prostate cancer","volume":"24","author":"Sidorova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"Ca. Cancer J. Clin."},{"key":"B113","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.3892\/or.2020.7791","article-title":"Lipid-based nanoparticles for the therapeutic delivery of non-coding RNAs in breast cancer (Review)","volume":"44","author":"Silva-Cazares","year":"2020","journal-title":"Oncol. Rep."},{"key":"B114","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","article-title":"Planning for tomorrow: Global cancer incidence and the role of prevention 2020\u20132070","volume":"18","author":"Soerjomataram","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.3390\/molecules25204701","article-title":"Participation of MicroRNAs in the treatment of cancer with phytochemicals","volume":"25","author":"Son","year":"2020","journal-title":"Molecules"},{"key":"B116","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1039\/D0TB00346H","article-title":"Efficient co-delivery of microRNA 21 inhibitor and doxorubicin to cancer cells using core-shell tecto dendrimers formed via supramolecular host-guest assembly","volume":"8","author":"Song","year":"2020","journal-title":"J. Mat. Chem. B"},{"key":"B117","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.semcancer.2022.05.012","article-title":"Perspectives of using microRNA-loaded nanocarriers for epigenetic reprogramming of drug resistant colorectal cancers","volume":"86","author":"Sukocheva","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"12281","DOI":"10.1021\/acsnano.9b09713","article-title":"What went wrong with anticancer nanomedicine design and how to make it right","volume":"14","author":"Sun","year":"2020","journal-title":"ACS Nano"},{"key":"B119","doi-asserted-by":"publisher","first-page":"115417","DOI":"10.1016\/j.molliq.2021.115417","article-title":"Mesoporous silica nanoparticles as a versatile nanocarrier for cancer treatment: A review","volume":"328","author":"Taleghani","year":"2021","journal-title":"J. Mol. Liq."},{"key":"B120","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fbioe.2020.00184","article-title":"Emerging and innovative theranostic approaches for mesoporous silica nanoparticles in hepatocellular carcinoma: Current status and advances","volume":"8","author":"Tao","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/jcm9010084","article-title":"Tumor angiogenesis and anti-angiogenic strategies for cancer treatment","volume":"9","author":"Teleanu","year":"2020","journal-title":"J. Clin. Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3390\/biom11071015","article-title":"Peroxidase mimetic nanozymes in cancer phototherapy: Progress and perspectives","volume":"11","author":"Thangudu","year":"2021","journal-title":"Biomolecules"},{"key":"B123","doi-asserted-by":"publisher","first-page":"103550","DOI":"10.1016\/j.pdpdt.2023.103550","article-title":"Fourier transform infrared spectroscopic marker of glioblastoma obtained from machine learning and changes in the spectra","volume":"42","author":"To\u0142pa","year":"2023","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"B124","doi-asserted-by":"publisher","first-page":"642794","DOI":"10.3389\/fbioe.2021.642794","article-title":"Plant virus nanoparticles for anti-cancer therapy","volume":"9","author":"Venkataraman","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"121056","DOI":"10.1016\/j.biomaterials.2021.121056","article-title":"Designer exosomes enabling tumor targeted efficient chemo\/gene\/photothermal therapy","volume":"276","author":"Wang","year":"","journal-title":"Biomaterials"},{"key":"B126","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jconrel.2020.12.007","article-title":"Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistance","volume":"330","author":"Wang","year":"","journal-title":"J. Control. Release"},{"key":"B127","doi-asserted-by":"publisher","first-page":"116305","DOI":"10.1016\/j.bmc.2021.116305","article-title":"Self-assembly of photosensitive and radiotherapeutic peptide for combined photodynamic-radio cancer therapy with intracellular delivery of miRNA-139-5p","volume":"44","author":"Wang","year":"","journal-title":"Bioorg. Med. Chem."},{"key":"B128","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.7150\/thno.57828","article-title":"Recent progress in nanomedicine for enhanced cancer chemotherapy","volume":"11","author":"Wei","year":"2021","journal-title":"Theranostics"},{"key":"B129","doi-asserted-by":"publisher","first-page":"109473","DOI":"10.1016\/j.biopha.2019.109473","article-title":"Dual delivery nanoscale device for miR-451 and adriamycin co-delivery to combat multidrug resistant in bladder cancer","volume":"122","author":"Wei","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B130","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12951-021-01181-z","article-title":"Nanomedicine-enabled chemotherapy-based synergetic cancer treatments","volume":"20","author":"Wu","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"B131","doi-asserted-by":"publisher","first-page":"100742","DOI":"10.1016\/j.jhepr.2023.100742","article-title":"Endogenous sex steroid hormones and risk of liver cancer among U.S. Men: Results from the liver cancer pooling project","volume":"2023","author":"Wu","year":"2023","journal-title":"JHEP Rep."},{"key":"B132","doi-asserted-by":"publisher","first-page":"101019","DOI":"10.1016\/j.mtchem.2022.101019","article-title":"Development of fullerene nanospherical miRNA and application in overcoming resistant breast cancer","volume":"26","author":"Xu","year":"2022","journal-title":"Mat. Today Chem."},{"key":"B133","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.apsb.2021.08.011","article-title":"Inhibiting collagen I production and tumor cell colonization in the lung via miR-29a-3p loading of exosome-\/liposome-based nanovesicles","volume":"12","author":"Yan","year":"","journal-title":"Acta Pharm. Sin. B"},{"key":"B134","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.cclet.2021.08.018","article-title":"Let-7i miRNA and platinum loaded nano-graphene oxide platform for detection\/reversion of drug resistance and synergetic chemical-photothermal inhibition of cancer cell","volume":"33","author":"Yan","year":"","journal-title":"Chin. Chem. Lett."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.vaccine.2019.11.031","article-title":"An overview of biodegradable nanomaterials and applications in vaccines","volume":"38","author":"Yan","year":"2020","journal-title":"Vaccine"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.bioactmat.2020.12.010","article-title":"The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment","volume":"6","author":"Yang","year":"","journal-title":"Bioact. Mat."},{"key":"B137","doi-asserted-by":"publisher","first-page":"771551","DOI":"10.3389\/fimmu.2021.771551","article-title":"Immune cell-derived extracellular vesicles \u2013 new strategies in cancer immunotherapy","volume":"12","author":"Yang","year":"","journal-title":"Front. Immunol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"584391","DOI":"10.3389\/fbioe.2020.584391","article-title":"Plant-derived nanovesicles: A novel form of nanomedicine","volume":"8","author":"Yu","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s40820-022-00828-2","article-title":"Nanozymes: Versatile platforms for cancer diagnosis and therapy","volume":"14","author":"Zhang","year":"2022","journal-title":"Nano-Micro Lett."},{"key":"B140","doi-asserted-by":"publisher","first-page":"2103812","DOI":"10.1002\/advs.202103812","article-title":"Anti-MicroRNA-21 oligonucleotide loaded spermine-modified acetalated dextran nanoparticles for B1 receptor-targeted gene therapy and antiangiogenesis therapy","volume":"9","author":"Zheng","year":"2022","journal-title":"Adv. Sci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"117368","DOI":"10.1016\/j.neuroimage.2020.117368","article-title":"(TS)2WM: Tumor segmentation and tract statistics for assessing white matter integrity with applications to glioblastoma patients","volume":"223","author":"Zhong","year":"2020","journal-title":"Neuroimage"},{"key":"B142","doi-asserted-by":"publisher","first-page":"2100556","DOI":"10.1002\/adma.202100556","article-title":"Multifunctional graphdiyne\u2013cerium oxide nanozymes facilitate MicroRNA delivery and attenuate tumor hypoxia for highly efficient radiotherapy of esophageal cancer","volume":"33","author":"Zhou","year":"2021","journal-title":"Adv. Mat."}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2023.1208547\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T10:26:34Z","timestamp":1690453594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2023.1208547\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":142,"alternative-id":["10.3389\/fbioe.2023.1208547"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2023.1208547","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]},"article-number":"1208547"}}